Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy Volunteers
Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
To investigate the steady-state pharmacokinetics of once-daily and twice-daily regimens of
BIA 2-093 and twice-daily regimen of Oxcarbazepine (Trileptal®) in healthy subjects and to
assess the tolerability of such regimens in healthy subjects.